OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Through an extensive portfolio of high-performance stents and balloons, OrbusNeich provides proven solutions to interventional cardiologists worldwide.


Genous Achieves Good, Comparable Clinical Outcomes in Patients discontinuing DAPT at 30 Days and at 6 Months... READ MORE...

Use of Genous Stent in Bifurcations Is Feasible and Safe with No Incidence of Late Stent Thrombosis... READ MORE...



OrbusNeich leads the way in pro-healing stent technology with the Genous™ Stent, the world's first pro-healing stent.
Development stage products include the Combo™ Dual Therapy Stent, the only dual therapy stent to both accelerate endothelial coverage and control neo-intimal proliferation through the combination of the Genous pro-healing technology with an abluminal sirolimus drug elution.


Visit us at Internatiional Congress of Cardiology, February 24-26, Hong Kong... READ MORE...

Visit us at the 78th Annual Convention of the German Cardiac Society, April 11-14, Mannheim, Germany... READ MORE...